Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Jun;62(6):2158–2164. doi: 10.1128/iai.62.6.2158-2164.1994

Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.

A N Neely 1, R G Miller 1, I A Holder 1
PMCID: PMC186492  PMID: 8188336

Abstract

Circulating proteolytic activity (PA) increases following burn or surgical trauma. Challenging traumatized mice with the yeast Candida albicans further increases PA. Once a PA threshold has been passed, mortality increases as PA increases. The purposes of this study were to determine (i) if gram-negative bacterial challenge affects circulating PA and mortality as Candida challenge does and (ii) if proteinase inhibitor treatment with aprotinin, antithrombin III, and alpha 1-proteinase inhibitor decreases circulating PA and increases the survival of burned mice infected with a bacterium. For all bacteria tested (Proteus mirabilis, Pseudomonas aeruginosa, and Klebsiella pneumoniae), burn plus challenge significantly elevated PA and mortality above levels in mice that were only burned or only challenged. Quantitative culture counts indicated that the mice died of sepsis. Proteinase inhibitor treatment of mice burned and challenged with K. pneumoniae significantly decreased circulating PA, decreased the hepatic microbial load, and increased survival. Hence, in traumatized mice challenged with either C. albicans or gram-negative bacteria, a relationship exists between proteolytic load and subsequent septic death. Parallels between these animal studies and human studies are discussed.

Full text

PDF
2158

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aasen A. O. The proenzyme functional inhibition index. A new parameter for evaluation of the severely injured and septic patient. Acta Chir Scand Suppl. 1985;522:211–231. [PubMed] [Google Scholar]
  2. Benichoux R. Aprotinin and blood loss in open heart surgery. Lancet. 1988 May 28;1(8596):1226–1226. doi: 10.1016/s0140-6736(88)92044-2. [DOI] [PubMed] [Google Scholar]
  3. Blauhut B., Kramar H., Vinazzer H., Bergmann H. Substitution of antithrombin III in shock and DIC: a randomized study. Thromb Res. 1985 Jul 1;39(1):81–89. doi: 10.1016/0049-3848(85)90123-9. [DOI] [PubMed] [Google Scholar]
  4. Büller H. R., Bolwerk C., ten Cate J., Roos J., Kahlé L. H., ten Cate J. W. Postoperative hemostatic profile in relation to gram-negative septicemia. Crit Care Med. 1982 May;10(5):311–315. [PubMed] [Google Scholar]
  5. Colman R. W. The role of plasma proteases in septic shock. N Engl J Med. 1989 May 4;320(18):1207–1209. doi: 10.1056/NEJM198905043201809. [DOI] [PubMed] [Google Scholar]
  6. Cryz S. J., Jr, Fürer E., Germanier R. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide. Infect Immun. 1984 Jul;45(1):139–142. doi: 10.1128/iai.45.1.139-142.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Daniels J. C., Larson D. L., Abston S., Ritzmann S. E. Serum protein profiles in thermal burns. II. Protease inhibitors, complement factors, and c-reactive protein. J Trauma. 1974 Feb;14(2):153–162. doi: 10.1097/00005373-197402000-00007. [DOI] [PubMed] [Google Scholar]
  8. Demling R. H., Wong C., Jin L. J., Hechtman H., Lalonde C., West K. Early lung dysfunction after major burns: role of edema and vasoactive mediators. J Trauma. 1985 Oct;25(10):959–966. [PubMed] [Google Scholar]
  9. Duswald K. H., Jochum M., Schramm W., Fritz H. Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery. 1985 Nov;98(5):892–899. [PubMed] [Google Scholar]
  10. Fourrier F., Chopin C., Goudemand J., Hendrycx S., Caron C., Rime A., Marey A., Lestavel P. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest. 1992 Mar;101(3):816–823. doi: 10.1378/chest.101.3.816. [DOI] [PubMed] [Google Scholar]
  11. Fourrier F., Lestavel P., Chopin C., Marey A., Goudemand J., Rime A., Mangalaboyi J. Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med. 1990;16(2):121–124. doi: 10.1007/BF02575306. [DOI] [PubMed] [Google Scholar]
  12. Fritz H., Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung. 1983;33(4):479–494. [PubMed] [Google Scholar]
  13. Gallagher P. G., Watanakunakorn C. Pseudomonas bacteremia in a community teaching hospital, 1980-1984. Rev Infect Dis. 1989 Nov-Dec;11(6):846–852. doi: 10.1093/clinids/11.6.846. [DOI] [PubMed] [Google Scholar]
  14. Haddy R. I., Lee M., 3rd, Sangal S. P., Walbroehl G. S., Hambrick C. S., Sarti G. M. Klebsiella pneumoniae bacteremia in the community hospital. J Fam Pract. 1989 Jun;28(6):686–690. [PubMed] [Google Scholar]
  15. Highsmith R. F., Rosenberg R. D. A rapid and sensitive proteolytic assay for human plasminogen and plasmin using radioiodinated alpha-casein. Thromb Res. 1977 Aug;11(2):131–140. doi: 10.1016/0049-3848(77)90031-7. [DOI] [PubMed] [Google Scholar]
  16. Holder I. A., Neely A. N. Hageman factor-dependent kinin activation in burns and its theoretical relationship to postburn immunosuppression syndrome and infection. J Burn Care Rehabil. 1990 Nov-Dec;11(6):496–503. doi: 10.1097/00004630-199011000-00003. [DOI] [PubMed] [Google Scholar]
  17. Holder I. A., Neely A. N. Pseudomonas elastase acts as a virulence factor in burned hosts by Hageman factor-dependent activation of the host kinin cascade. Infect Immun. 1989 Nov;57(11):3345–3348. doi: 10.1128/iai.57.11.3345-3348.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kaminishi H., Tanaka M., Cho T., Maeda H., Hagihara Y. Activation of the plasma kallikrein-kinin system by Candida albicans proteinase. Infect Immun. 1990 Jul;58(7):2139–2143. doi: 10.1128/iai.58.7.2139-2143.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Loomes L. M., Senior B. W., Kerr M. A. Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients. Infect Immun. 1992 Jun;60(6):2267–2273. doi: 10.1128/iai.60.6.2267-2273.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. McMichan J. C., Rosengarten D. S., Philipp E. Prophylaxis of post-traumatic pulmonary insufficiency by protease-inhibitor therapy with aprotinin: a clinical study. Circ Shock. 1982;9(2):107–116. [PubMed] [Google Scholar]
  21. Miller R. G., Neely A. N. Surgical trauma, Candida infection, and serum proteolytic activity. J Surg Res. 1992 Sep;53(3):263–267. doi: 10.1016/0022-4804(92)90045-2. [DOI] [PubMed] [Google Scholar]
  22. Molla A., Yamamoto T., Akaike T., Miyoshi S., Maeda H. Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases. J Biol Chem. 1989 Jun 25;264(18):10589–10594. [PubMed] [Google Scholar]
  23. Morihara K., Tsuzuki H., Oda K. Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor. Infect Immun. 1979 Apr;24(1):188–193. doi: 10.1128/iai.24.1.188-193.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Neely A. N., Holder I. A. Effect of proteolytic activity on virulence of Candida albicans in burned mice. Infect Immun. 1990 Jun;58(6):1527–1531. doi: 10.1128/iai.58.6.1527-1531.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Neely A. N., Nathan P., Highsmith R. F. Plasma proteolytic activity following burns. J Trauma. 1988 Mar;28(3):362–367. doi: 10.1097/00005373-198803000-00012. [DOI] [PubMed] [Google Scholar]
  26. Neely A. N., Warden G. D., Rieman M., Friedberg D. L., Holder I. A. Components of the increased circulating proteolytic activity in pediatric burn patients. J Trauma. 1992 Dec;33(6):807–812. doi: 10.1097/00005373-199212000-00002. [DOI] [PubMed] [Google Scholar]
  27. Ozkan A. N., Pinney E., Hoyt D. B., Ninnemann J., Hansbrough J. Elastase and suppressor active peptide activity following burn injury. J Trauma. 1988 Feb;28(2):207–210. doi: 10.1097/00005373-198802000-00014. [DOI] [PubMed] [Google Scholar]
  28. Risberg B., Medegård A., Heideman M., Gyzander E., Bundsen P., Odén M., Teger-Nilsson A. C. Early activation of humoral proteolytic systems in patients with multiple trauma. Crit Care Med. 1986 Nov;14(11):917–925. doi: 10.1097/00003246-198611000-00001. [DOI] [PubMed] [Google Scholar]
  29. Royston D., Bidstrup B. P., Taylor K. M., Sapsford R. N. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987 Dec 5;2(8571):1289–1291. doi: 10.1016/s0140-6736(87)91190-1. [DOI] [PubMed] [Google Scholar]
  30. Rund T. E., Kierulf P., Godal H. C., Aune S., Aasen A. O. Studies on pathological plasma proteolysis in severely burned patients using chromogenic peptide substrate assays: a preliminary report. Adv Exp Med Biol. 1984;167:449–454. doi: 10.1007/978-1-4615-9355-3_39. [DOI] [PubMed] [Google Scholar]
  31. Rüchel R. Properties of a purified proteinase from the yeast Candida albicans. Biochim Biophys Acta. 1981 May 14;659(1):99–113. doi: 10.1016/0005-2744(81)90274-6. [DOI] [PubMed] [Google Scholar]
  32. Schipper H. G., Jenkins C. S., Kahlé L. H., ten Cate J. W. Antithrombin-III transfusion in disseminated intravascular coagulation. Lancet. 1978 Apr 22;1(8069):854–856. doi: 10.1016/s0140-6736(78)90196-4. [DOI] [PubMed] [Google Scholar]
  33. Siebeck M., Spannagl M., Hoffmann H., Fink E. Effects of protease inhibitors in experimental septic shock. Agents Actions Suppl. 1992;38(Pt 3):421–427. [PubMed] [Google Scholar]
  34. Speer C. P., Rethwilm M., Gahr M. Elastase-alpha 1-proteinase inhibitor: an early indicator of septicemia and bacterial meningitis in children. J Pediatr. 1987 Nov;111(5):667–671. doi: 10.1016/s0022-3476(87)80240-8. [DOI] [PubMed] [Google Scholar]
  35. Stieritz D. D., Holder I. A. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J Infect Dis. 1975 Jun;131(6):688–691. doi: 10.1093/infdis/131.6.688. [DOI] [PubMed] [Google Scholar]
  36. Straus D. C. Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae. Infect Immun. 1987 Jan;55(1):44–48. doi: 10.1128/iai.55.1.44-48.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wolff S. M. Monoclonal antibodies and the treatment of gram-negative bacteremia and shock. N Engl J Med. 1991 Feb 14;324(7):486–488. doi: 10.1056/NEJM199102143240709. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES